157 related articles for article (PubMed ID: 17459487)
21. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
[TBL] [Abstract][Full Text] [Related]
22. The topical niacin sensitivity test: an inter- and intra-rater reliability study in healthy controls.
Kerr M; Cotton S; Proffitt T; McConchie M; Markulev C; Smesny S; McGorry P; Berger G
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):15-9. PubMed ID: 18656334
[TBL] [Abstract][Full Text] [Related]
23. A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.
Lien YJ; Huang SS; Liu CM; Hwu HG; Faraone SV; Tsuang MT; Chen WJ
Schizophr Bull; 2013 Jan; 39(1):68-76. PubMed ID: 21653277
[TBL] [Abstract][Full Text] [Related]
24. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Messamore E; Hoffman WF; Yao JK
Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
[TBL] [Abstract][Full Text] [Related]
25. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL
Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306
[TBL] [Abstract][Full Text] [Related]
26. Niacin skin flush in schizophrenia: a preliminary report.
Ward PE; Sutherland J; Glen EM; Glen AI
Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
[TBL] [Abstract][Full Text] [Related]
27. Negative correlation between cerebral inorganic phosphate and the volumetric niacin response in male patients with schizophrenia who have seriously and dangerously violently offended: a (31)P magnetic resonance spectroscopy study.
Puri BK; Richardson AJ; Counsell SJ; Ward PE; Bustos MG; Hamilton G; Bhakoo KK; Treasaden IH
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):97-9. PubMed ID: 17765531
[TBL] [Abstract][Full Text] [Related]
28. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.
Yao JK; Dougherty GG; Gautier CH; Haas GL; Condray R; Kasckow JW; Kisslinger BL; Gurklis JA; Messamore E
Schizophr Bull; 2016 Mar; 42(2):369-76. PubMed ID: 26371338
[TBL] [Abstract][Full Text] [Related]
30. [The niacin test in schizophrenia].
Weterle R; Rybakowski J
Psychiatr Pol; 1990; 24(2):116-20. PubMed ID: 2084715
[TBL] [Abstract][Full Text] [Related]
31. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
Smesny S; Rosburg T; Baur K; Rudolph N; Sauer H
Neuropsychopharmacology; 2007 Oct; 32(10):2067-73. PubMed ID: 17314920
[TBL] [Abstract][Full Text] [Related]
33. Attenuated niacin skin flushing response in children and adolescents with mental disorders: A transdiagnostic early warning marker.
Qing Y; Liang J; Wang J; Wan C; Ke X
Schizophr Res; 2022 Oct; 248():32-34. PubMed ID: 35933741
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of axis I antecedents before age 18 of unipolar depression, bipolar disorder and schizophrenia.
Rubino IA; Frank E; Croce Nanni R; Pozzi D; Lanza di Scalea T; Siracusano A
Psychopathology; 2009; 42(5):325-32. PubMed ID: 19672135
[TBL] [Abstract][Full Text] [Related]
35. Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interview.
Kamal-Bahl S; Watson DJ; Ambegaonkar BM
Clin Ther; 2009 Jan; 31(1):130-40. PubMed ID: 19243714
[TBL] [Abstract][Full Text] [Related]
36. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
37. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
Messamore E
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):413-9. PubMed ID: 14623495
[TBL] [Abstract][Full Text] [Related]
38. Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model.
Papaliodis D; Boucher W; Kempuraj D; Michaelian M; Wolfberg A; House M; Theoharides TC
J Pharmacol Exp Ther; 2008 Dec; 327(3):665-72. PubMed ID: 18784348
[TBL] [Abstract][Full Text] [Related]
39. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
[TBL] [Abstract][Full Text] [Related]
40. Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight.
Yen CF; Cheng CP; Huang CF; Ko CH; Yen JY; Chang YP; Chen CS
Bipolar Disord; 2009 Mar; 11(2):190-7. PubMed ID: 19267701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
